rs200515712
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_006267.5(RANBP2):c.2625A>G(p.Val875Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000263 in 1,596,240 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00019 ( 0 hom., cov: 27)
Exomes 𝑓: 0.00027 ( 4 hom. )
Consequence
RANBP2
NM_006267.5 synonymous
NM_006267.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.213
Publications
1 publications found
Genes affected
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
- familial acute necrotizing encephalopathyInheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 2-108762123-A-G is Benign according to our data. Variant chr2-108762123-A-G is described in ClinVar as Benign. ClinVar VariationId is 469443.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.213 with no splicing effect.
BS2
High AC in GnomAd4 at 29 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RANBP2 | ENST00000283195.11 | c.2625A>G | p.Val875Val | synonymous_variant | Exon 19 of 29 | 1 | NM_006267.5 | ENSP00000283195.6 | ||
| RANBP2 | ENST00000697737.1 | c.2602+3575A>G | intron_variant | Intron 18 of 26 | ENSP00000513426.1 | |||||
| RANBP2 | ENST00000697740.1 | c.2524+3575A>G | intron_variant | Intron 18 of 26 | ENSP00000513427.1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 151628Hom.: 0 Cov.: 27 show subpopulations
GnomAD3 genomes
AF:
AC:
29
AN:
151628
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000314 AC: 74AN: 235626 AF XY: 0.000302 show subpopulations
GnomAD2 exomes
AF:
AC:
74
AN:
235626
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000271 AC: 391AN: 1444494Hom.: 4 Cov.: 31 AF XY: 0.000271 AC XY: 195AN XY: 718970 show subpopulations
GnomAD4 exome
AF:
AC:
391
AN:
1444494
Hom.:
Cov.:
31
AF XY:
AC XY:
195
AN XY:
718970
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33358
American (AMR)
AF:
AC:
0
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26100
East Asian (EAS)
AF:
AC:
373
AN:
39580
South Asian (SAS)
AF:
AC:
6
AN:
86080
European-Finnish (FIN)
AF:
AC:
0
AN:
39118
Middle Eastern (MID)
AF:
AC:
0
AN:
4130
European-Non Finnish (NFE)
AF:
AC:
4
AN:
1111352
Other (OTH)
AF:
AC:
6
AN:
60080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000191 AC: 29AN: 151746Hom.: 0 Cov.: 27 AF XY: 0.000229 AC XY: 17AN XY: 74140 show subpopulations
GnomAD4 genome
AF:
AC:
29
AN:
151746
Hom.:
Cov.:
27
AF XY:
AC XY:
17
AN XY:
74140
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41368
American (AMR)
AF:
AC:
0
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
25
AN:
5168
South Asian (SAS)
AF:
AC:
1
AN:
4774
European-Finnish (FIN)
AF:
AC:
0
AN:
10490
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67930
Other (OTH)
AF:
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.534
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Familial acute necrotizing encephalopathy Benign:1
Jun 04, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.